Samsung NeuroLogica

What Samsung NeuroLogica does

Samsung NeuroLogica is a US-based medical imaging company that develops, manufactures, and markets mobile computed tomography (CT) scanners for point-of-care deployment in hospitals, intensive care units, surgical environments, stroke centers, pediatric facilities, and radiation oncology departments. The company was founded in 2004 and was acquired by Samsung Electronics in 2013, now operating as a wholly-owned subsidiary within Samsung Healthcare's medical imaging division. Its product portfolio comprises four mobile CT systems: the BodyTom 64 (full-body imaging for ICU, interventional radiology, surgery, and pediatrics), the CereTom Elite (compact scanner for neuro and critical care brain/neck imaging), the OmniTom Elite (advanced 16-slice high-resolution mobile CT), and the OmniTom Elite with PCD, which is among the first commercial mobile CT platforms incorporating photon-counting detector technology for enhanced spectral imaging. Core technology centers on miniaturized, mobile CT hardware platforms that bring imaging to the patient rather than requiring patient transport to fixed rooms, with proprietary detector and form-factor designs differentiating the line from traditional fixed-room CT incumbents.

The company operates an enterprise field-sales go-to-market, selling capital equipment directly to healthcare institutions via Samsung Healthcare's sales organization with quote-based pricing and multi-year contracts. Distribution leverages Samsung Healthcare's global network, and the company maintains clinical training, compliance, and service infrastructure to support installed systems. Revenue is generated primarily through hardware sales of the BodyTom, CereTom, and OmniTom product lines, supplemented by post-sale service. Customer segments span hospital systems, ICUs, surgical suites, mobile stroke units, pediatric care facilities, and radiation oncology departments, with six explicitly marketed specialty clinical lines supporting use-case depth. As a subsidiary of Samsung Electronics, Samsung NeuroLogica benefits from parent-level R&D, brand recognition, and global distribution reach, while concentrating its own efforts on mobile CT platform innovation and clinical workflow integration.

Name

Samsung NeuroLogica

Legal name

Samsung NeuroLogica

Website

https://samsungneurologica.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

Samsung NeuroLogica is a US-based subsidiary of Samsung Electronics that develops and sells mobile CT scanners (BodyTom, CereTom, OmniTom, OmniTom Elite with PCD) for point-of-care imaging in hospitals, ICUs, surgical suites, stroke centers, and pediatric and oncology departments worldwide.

Ownership category

akta.pro rank

Product category

Mobile Medical Imaging Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)

akta.pro secondary industry

Computed Tomography (CT) Systems (HLAHABAB)

Keywords

• Mobile CT scanners
• Point-of-care imaging
• Medical imaging equipment
• Photon-counting CT
• Portable computed tomography

Headquarters

HQ city

Danvers

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Mobile CT Scanner Sales: Sale of mobile computed tomography scanner systems including BodyTom, CereTom, and OmniTom product lines. Products are sold directly to healthcare institutions as capital equipment purchases.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Samsung NeuroLogica develops, manufactures, and markets mobile computed tomography (CT) scanner systems for point-of-care imaging in healthcare environments. Its product line includes the BodyTom 64 (full-body mobile CT), CereTom Elite (compact neuro/critical care CT), OmniTom Elite (16-slice high-resolution mobile CT), and OmniTom Elite with PCD (photon-counting detector CT). These scanners are sold as capital equipment to hospitals, ICUs, surgical centers, stroke units, and specialty care facilities.

Product overview

Samsung NeuroLogica offers a portfolio of mobile computed tomography (CT) scanners under the Samsung Healthcare brand. The product line includes four distinct mobile CT systems: BodyTom® 64 (full-body imaging for ICU, interventional radiology, surgery, and pediatrics), CereTom® Elite (compact scanner for brain and neck imaging in neuro and critical care), OmniTom® Elite (advanced high-resolution imaging for neuro, head, and neck applications), and OmniTom® Elite with PCD (photon-counting CT for ultra-detailed imaging in advanced neuro, head, and research applications). These mobile CT solutions transform fixed imaging technologies into point-of-care platforms, bringing innovative imaging to patients.

Differentiator

Problem solved

Functional benefit

Brands

• BodyTom: Full-body mobile CT scanner for pediatric and adult ICU, interventional radiology, surgery, and critical care environments.
• CereTom
• OmniTom

Products and services

• BodyTom® 64 Full-body mobile CT scanner delivering high-quality imaging for pediatric and adult ICU, interventional radiology support, surgery, and other critical care environments. Designed for healthcare institutions needing point-of-care imaging.
• CereTom® Elite Compact mobile CT providing rapid brain and neck imaging for neuro and critical care cases. Targeted at ICUs, emergency departments, and neuro specialty care.
• OmniTom® Elite Advanced mobile CT with high-resolution 16-slice cone beam imaging for neuro, head, and neck applications. Designed for advanced clinical and research imaging needs.
• OmniTom® Elite with PCD Photon-counting CT offering ultra-detailed imaging for advanced neuro, head, and research applications. Incorporates next-generation PCD technology for enhanced spectral resolution.

Quantifiable outcome

• Mobile CT enables imaging to be brought to critically ill patients rather than transporting them to fixed equipment

Named customers1 record

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Brainlab: Developer of intraoperative imaging, surgical navigation, and image-guided surgery platforms used in operating rooms. Comparable in the surgical/OR and interventional use cases Samsung NeuroLogica targets, with overlapping hospital buyer personas.
• Carestream Health: Provides mobile and portable X-ray imaging systems used in ICUs, ERs, and hospital wards. Comparable in the point-of-care mobile imaging segment, competing for similar bedside/ward imaging budgets in hospitals.
• Stryker (Surgical Imaging): Through its Surgical Technologies and Endoscopy divisions, Stryker provides intraoperative and surgical imaging platforms used in operating rooms. Comparable as a competitor in the surgical/OR imaging niche that Samsung NeuroLogica's BodyTom and intraoperative positioning targets.
• Fujifilm Healthcare: Offers mobile X-ray, portable ultrasound, and broader imaging solutions into hospital and emergency settings. Comparable in mobile/portable imaging sold into hospitals, with overlapping enterprise sales motion, though focused on different modalities.
• Hyperfine: Developer of the Swoop portable MRI system, the most direct pure-play peer in point-of-care/portable advanced imaging. Comparable in mission (bringing advanced imaging to the bedside) and target buyers (ICUs, ERs, stroke units), but operates in MRI rather than CT.

Broad incumbents

• Philips Healthcare: Major imaging OEM with CT systems used in hospital and critical care environments. Comparable as an enterprise hospital imaging vendor competing for capital budgets that could otherwise be allocated to Samsung NeuroLogica's mobile CT systems.
• GE HealthCare: One of the largest global medical imaging OEMs with a broad CT portfolio (including mobile/portable CT systems) and full modality coverage. Comparable as a CT competitor with deeper hospital relationships and bundled sales capabilities, but far broader in scope than Samsung NeuroLogica.
• Canon Medical Systems: Imaging OEM offering a range of CT systems used in hospital, interventional, and emergency settings. Comparable as a competing CT vendor with similar enterprise sales motion into hospitals and specialty care facilities.
• Siemens Healthineers: Global imaging leader offering fixed and mobile CT systems, including photon-counting CT (NAEOTOM Alpha), directly competing with Samsung NeuroLogica's mobile and PCD capabilities. Comparable on CT technology overlap, though it operates across a much wider imaging portfolio.

Regional players

• Hologic: Medical imaging and surgical solutions company with a strong presence in women's health and surgical imaging, including some interventional and surgical imaging adjacencies. Comparable in imaging/medical device distribution to hospitals and surgical suites, but with a more focused specialty footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@SamsungHealthcareUSA
• Facebookfacebook.com/SamsungHealthcare.US
• LinkedInlinkedin.com/company/samsung-healthcare-usa
• Instagraminstagram.com/samsunghealthcare.us
• Xx.com/SamsungHealthUS

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Samsung NeuroLogica